Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
Condition(s):Polypoidal Choroidal VasculopathyLast Updated:April 12, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Polypoidal Choroidal VasculopathyLast Updated:April 12, 2023Recruiting
Condition(s):Center-involved Diabetic Macular EdemaLast Updated:February 28, 2020Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 13, 2016Unknown status
Condition(s):Macular Degeneration; Wet Macular DegenerationLast Updated:March 25, 2021Completed
Condition(s):Polypoidal Choroidal VasculopathyLast Updated:November 23, 2016Completed
Condition(s):Diabetic Macular EdemaLast Updated:December 1, 2022Completed
Condition(s):NeoplasmsLast Updated:March 29, 2018Terminated
Condition(s):Central Serous ChorioretinopathyLast Updated:June 16, 2017Completed
Condition(s):Metastatic Colorectal CancerLast Updated:April 11, 2019Completed
Condition(s):Exudative Age-related Macular DegenerationLast Updated:October 30, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.